Biocept Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund
Proceeds from the agreement will be used to fund
After a registration statement related to the transaction has been filed and declared effective by the
"This agreement affords us added balance sheet strength and flexibility as we further expand our menu of commercial assays and continue to drive physician adoption," said
Under the agreement, Aspire has committed to purchase the remaining
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Details of the purchase agreement and registration rights agreement were filed with the
About
About
Forward-Looking Statements
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although
Logo - http://photos.prnewswire.com/prnh/20151013/276540LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocept-announces-15-million-common-stock-purchase-agreement-with-aspire-capital-fund-300196142.html
SOURCE
News Provided by Acquire Media